Lower riskDrug recall · FDA · Published August 17, 2022
Padagis Triamcinolone Cream Recall: Gritty Texture and Lack of Effectiveness
Padagis recalls 0.1% Triamcinolone Acetonide Cream due to reports of gritty texture and lack of effectiveness. This prescription cream may not work as intended for skin conditions.
“Padagis Triamcinolone Cream Recall: Gritty Texture and Lack of Effectiveness.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34362-padagis-triamcinolone-cream-recall-gritty-texture-and-lack-of-effectiveness. Based on FDA recall #D-1497-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1497-2022%22&limit=1).
Padagis US LLC voluntarily recalled Triamcinolone Acetonide Cream USP, 0.1%, 80 g tubes on Aug. 17, 2022, due to current good manufacturing practice deviations, the FDA said. The recall affects 57,816 tubes distributed nationwide.
How to tell if you have it
Brand: Padagis
Product: Triamcinolone Acetonide Cream USP, 0.1%, 80 g tube, Rx Only
Manufacturer: Perrigo, Bronx, NY 10457
Distributor: Perrigo, Allegan, MI 49010
NDC: 45802-064-36
Lot code: 2CT0486
Expiration date: 02/29/2024
The hazard
The FDA cited CGMP deviations, specifically product complaints reporting a gritty texture and lack of effectiveness. The recall was classified as Class II.
Context
GovInfoNow's records show Padagis US LLC has issued seven other recalls since Dec. 27, 2021. Recent similar recalls include a Padagis Nystatin Cream recall on June 23, 2026, and a Padagis Estradiol Gel recall on Feb. 6, 2025. Other recent recalls of similar products include a Sun Pharmaceutical Fluocinonide Cream recall on March 25, 2026, and a Glenmark Azelaic Acid Gel 15% recall on July 23, 2026.
How to tell if you have this one
Check for the 0.1% Triamcinolone Acetonide Cream 80g tube with lot number 2CT0486. This product was distributed by Perrigo in Allegan, Michigan and expires February 29, 2024.
Brand
Padagis
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number 2CT0486 on the tube to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1497-2022 (August 17, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1497-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.